Thompson IM - Search Results

1

Roles of Distal and Genic Methylation in the Development of Prostate Tumorigenesis Revealed by Genome-wide DNA Methylation Analysis.

Wang Y, Jadhav RR, Liu J, Wilson D, Chen Y, Thompson IM, Troyer DA, Hernandez J, Shi H, Leach RJ, Huang TH, Jin VX. Wang Y, et al. Among authors: thompson im. Sci Rep. 2016 Feb 29;6:22051. doi: 10.1038/srep22051. Sci Rep. 2016. PMID: 26924343 Free PMC article.

2

A reliable assessment of 8-oxo-2-deoxyguanosine levels in nuclear and mitochondrial DNA using the sodium iodide method to isolate DNA.

Hamilton ML, Guo Z, Fuller CD, Van Remmen H, Ward WF, Austad SN, Troyer DA, Thompson I, Richardson A. Hamilton ML, et al. Nucleic Acids Res. 2001 May 15;29(10):2117-26. doi: 10.1093/nar/29.10.2117. Nucleic Acids Res. 2001. PMID: 11353081 Free PMC article.

3

Androgen receptor length polymorphism associated with prostate cancer risk in Hispanic men.

Balic I, Graham ST, Troyer DA, Higgins BA, Pollock BH, Johnson-Pais TL, Thompson IM, Leach RJ. Balic I, et al. Among authors: thompson im. J Urol. 2002 Nov;168(5):2245-8. doi: 10.1016/S0022-5347(05)64364-9. J Urol. 2002. PMID: 12394768

4

Risk perceptions among patients and their relatives regarding prostate cancer and its heredity.

Arar N, Thompson I, Sarosdy M, Harris M, Shepherd D, Troyer D, Plaetke R. Arar N, et al. Prostate Cancer Prostatic Dis. 2000 Nov;3(3):176-185. doi: 10.1038/sj.pcan.4500416. Prostate Cancer Prostatic Dis. 2000. PMID: 12497094

5

Challenges and opportunities to the design and implementation of chemoprevention trials for prostate cancer.

Thompson IM, Basler JA, Leach R, Troyer D, Klein E, Brawley O. Thompson IM, et al. Urol Oncol. 2003 Jan-Feb;21(1):73-8. doi: 10.1016/s1078-1439(02)00302-2. Urol Oncol. 2003. PMID: 12684131 Review.

6

Prostate cancer prevention: what do we know now and when will we know more?

Thompson IM, Basler J, Hensley D, von Merveldt D, Jenkins CA, Higgins B, Leach R, Troyer D, Pollock B. Thompson IM, et al. Clin Prostate Cancer. 2003 Mar;1(4):215-20. doi: 10.3816/cgc.2003.n.002. Clin Prostate Cancer. 2003. PMID: 15040879 Review.

7

What's new in the field of prostate cancer chemoprevention?

Mahal K, Hernandez J, Basler JW, Thompson IM. Mahal K, et al. Among authors: thompson im. Curr Oncol Rep. 2004 May;6(3):237-42. doi: 10.1007/s11912-004-0055-9. Curr Oncol Rep. 2004. PMID: 15066236 Review.

8

Relationship of body mass index and prostate specific antigen in a population-based study.

Thompson IM, Leach R, Troyer D, Pollock B, Naylor S, Higgins B. Thompson IM, et al. Urol Oncol. 2004 Mar-Apr;22(2):127-31. doi: 10.1016/S1078-1439(03)00171-6. Urol Oncol. 2004. PMID: 15082010

9

The potential role of cyclooxygenase-2 inhibitors and 5alpha-reductase inhibitors in the prevention of urologic conditions.

Hernandez J, Basler JW, Thompson IM. Hernandez J, et al. Among authors: thompson im. Urol Clin North Am. 2004 May;31(2):213-8. doi: 10.1016/j.ucl.2004.01.009. Urol Clin North Am. 2004. PMID: 15123401 Review.

10

Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker.

Hernández J, Thompson IM. Hernández J, et al. Among authors: thompson im. Cancer. 2004 Sep 1;101(5):894-904. doi: 10.1002/cncr.20480. Cancer. 2004. PMID: 15329895 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

855 results

Search Page

Filters